Xerostomia (Dry Mouth Disease) Therapeutics Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32 - PowerPoint PPT Presentation

About This Presentation
Title:

Xerostomia (Dry Mouth Disease) Therapeutics Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32

Description:

According to the latest research report by IMARC Group, The global xerostomia (dry mouth disease) therapeutics market size reached US$ 739.8 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 985.0 Million by 2032, exhibiting a growth rate (CAGR) of 3.13% during 2024-2032. More Info:- – PowerPoint PPT presentation

Number of Views:1
Date added: 7 May 2024
Slides: 15
Provided by: MarcelMikaelson
Category:
Tags:

less

Transcript and Presenter's Notes

Title: Xerostomia (Dry Mouth Disease) Therapeutics Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32


1
Global Xerostomia (Dry Mouth Disease)
Therapeutics Market Research and Forecast Report
2024-2032
  • Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group
  • International Market Analysis Research and
    Consulting Group is a leading adviser on
    management strategy and market research
    worldwide. We partner with clients in all regions
    and industry verticals to identify their
    highest-value opportunities, address their most
    critical challenges, and transform their
    businesses.
  • IMARCs information products include major
    market, scientific, economic and technological
    developments for business leaders in
    pharmaceutical, industrial, and high technology
    organizations. Market forecasts and industry
    analysis for biotechnology, advanced materials,
    chemicals, food and beverage, travel and tourism,
    nanotechnology and novel processing methods are
    at the top of the companys expertise.
  • IMARCs tailored approach combines unfathomable
    insight into the dynamics of companies and
    markets with close cooperation at all levels of
    the client organization. This ensures that our
    clients achieve unmatchable competitive
    advantage, build more proficient organizations,
    and secure lasting results.

3
Report Highlight and Description
  • According to the latest report by IMARC Group,
    titled "Xerostomia (Dry Mouth Disease)
    Therapeutics Market Global Industry Trends,
    Share, Size, Growth, Opportunity and Forecast
    2024-2032," the global xerostomia (dry mouth
    disease) therapeutics market size reached US
    739.8 Million in 2023.
  • Xerostomia dry mouth disease therapeutics refer
    to a range of medical treatments and
    interventions that focus on alleviating the
    symptoms and addressing the underlying causes of
    xerostomia, which is commonly known as dry mouth
    disease. They are cost-effective, convenient to
    use, and widely available as saliva stimulating
    medications, saliva substitutes, oral lubricants,
    chewing gum and lozenges, and prescription
    toothpaste and mouthwash.
  • They can help stimulate the production of saliva
    in individuals and provide relief from dry mouth
    symptoms while improving overall oral comfort.
    They prevent dental issues, such as cavities,
    tooth decay, and gum disease, and maintain oral
    health. As they are beneficial in maintaining
    oral moisture and alleviating dryness and
    discomfort, the demand for xerostomia dry mouth
    disease therapeutics is increasing across the
    globe.
  • Request for a PDF sample of this report
    https//www.imarcgroup.com/xerostomia-therapeutics
    -market/requestsample

4
Report Description
  • Global Xerostomia (Dry Mouth Disease)
    Therapeutics Market Trends
  • At present, the rising prevalence of xerostomia
    among the masses represents one of the key
    factors impelling the market growth. Moreover,
    the increasing development of innovative and
    patient-friendly treatment options is
    strengthening the market growth. Apart from this,
    the escalating demand for sustainable and
    eco-friendly solutions that reduce environmental
    impact, along with the rising focus on enhancing
    patient comfort and quality of life, is
    positively influencing the market. In addition,
    increasing preferences for natural and bio-based
    ingredients in xerostomia therapeutics that are
    chemical-free are contributing to the market
    growth.
  • Besides this, advancements in drug delivery
    systems and formulation technologies for more
    effective and convenient dry mouth therapeutics
    are supporting the growth of the market.
    Furthermore, the rising awareness about the early
    diagnosis of xerostomia among individuals is
    providing lucrative growth opportunities to
    industry investors. In line with this, the rising
    focus on dental hygiene and preventive care among
    people is propelling the market growth.
    Additionally, the growing demand for xerostomia
    dry mouth disease therapeutics among the
    geriatric population, as they are more prone to
    dry mouth, is offering a favorable market
    outlook.
  • Looking forward, IMARC Group expects the market
    to reach US 985.0 Million by 2032, exhibiting a
    growth rate (CAGR) of 3.13 during 2024-2032.
  • View Report TOC, Figures and Tables
    https//www.imarcgroup.com/xerostomia-therapeutics
    -market

5
Report Segmentation
  • Breakup by Type
  • Artificial Saliva/Saliva Substitutes
  • Salivary Stimulants
  •  
  • Breakup by Drug Type
  • OTC
  • Prescription
  • Breakup by Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

6
Report Segmentation
  • Breakup by Region
  • North America
  • Asia-Pacific
  • Europe
  • Latin America
  • Middle East and Africa

7
Competitive Landscape with Key Players
  • 3M Company
  • Biotene (GSK plc)
  • Parnell Pharmaceuticals Inc.
  • Quest Products LLC
  • Saliwell Ltd
  • Sun Pharmaceutical Industries Limited
  • West-Ward Pharmaceutical (Hikma Pharmaceuticals
    plc).

8
Key Questions Answered in the Report
9
Table of Contents
  • 1    Preface2    Scope and Methodology    2.1  
     Objectives of the Study    2.2  
     Stakeholders    2.3    Data Sources       
    2.3.1    Primary Sources        2.3.2  
     Secondary Sources    2.4    Market Estimation 
          2.4.1    Bottom-Up Approach        2.4.2  
     Top-Down Approach    2.5    Forecasting
    Methodology3    Executive Summary4  
     Introduction    4.1    Overview    4.2    Key
    Industry Trends5    Global Xerostomia (Dry Mouth
    Disease) Therapeutics Market    5.1    Market
    Overview    5.2    Market Performance    5.3  
     Impact of COVID-19  5.4    Market Forecast
  • 6     Market Breakup by Type
  • 6.1 Artificial Saliva/Saliva Substitutes
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
  • 6.2 Salivary Stimulants
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
  • 7 Market Breakup by Drug Type
  • 7.1 OTC
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast       

10
Table of Contents
  • 7.2 Prescription
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
  • 8 Market Breakup by Distribution Channel
  • 8.1 Hospital Pharmacy
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacy
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
  • 8.3 Online Pharmacy
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
  • 9 Market Breakup by Region
  • 9.1 North America
  • 9.1.1 United States
  • 9.1.1.1 Market Trends
  • 9.1.1.2 Market Forecast
  • 9.1.2 Canada

11
Partial List of Clients
12
Partial List of Clients
13
Disclaimer
  • 2024 IMARC All Rights Reserved
  • This Publication and all its contents unless
    otherwise mentioned are copyrighted in the name
    of International Market Analysis Research and
    Consulting (IMARC). No part of this publication
    may be reproduced, repackaged, redistributed or
    resold in whole or in any part. The publication
    may also not be used in any form or by and means
    graphic electronic or mechanical, including
    photocopying, recording, taping or by information
    storage or retrieval, or by any other form,
    without the express consent of International
    Market Analysis Research and Consulting (IMARC).
  • Disclaimer All contents and data of this
    publication, including forecasts, data analysis
    and opinion have been based on information and
    sources believed to be accurate and reliable at
    the time of publishing. International Market
    Analysis Research and Consulting makes no
    representation of warranty of any kind as to the
    accuracy or completeness of any Information
    provided. IMARC accepts no liability whatsoever
    for any loss or damage resulting from opinion,
    errors or inaccuracies if any found this
    publication.
  • IMARC, IMARC Group and Global Therapy Insight
    Series are registered trademarks of International
    Market Analysis Research and Consulting. All
    other trademarks used in this publication are
    registered trademarks of their respective
    companies.

14
Contact Us
Visit us at
https//www.imarcgroup.com
1-631-791-1145
sales_at_imarcgroup.com
Stay With Us
Write a Comment
User Comments (0)
About PowerShow.com